The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 7, Issue 4, 2006, Pages 206-211

  Kassab, Salah Eldin ^a   Garadah, Taysir ^b   Abu Hijleb, Marwan ^a   Golbahar, Jamal ^a   Senok, Solomon ^a   Wazir, Javed ^a   Gumaa, Khalid ^a  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b Salmaneya Medical Complex ^*  (Bahrain)

Author keywords

Angiotensin II; AT1 receptors; Homocysteine; Left ventricular hypertrophy; Rats

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; COLLAGEN; HOMOCYSTEINE; METHIONINE; VALSARTAN;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HEART VENTRICLE REMODELING; HISTOPATHOLOGY; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MALE; NONHUMAN; RAT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; HYPERTROPHY, LEFT VENTRICULAR; MALE; ORGAN SIZE; RATS; RATS, INBRED F344; RECEPTOR, ANGIOTENSIN, TYPE 1; TETRAZOLES; VALINE; VENTRICULAR REMODELING;

EID: 33847751117     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2006.039     Document Type: Article

References (24)

1. Boers GH. Mild hyperhomocysteinemia is an independent risk factor of arterial vascular disease. Semin Thromb Hemost 2000;26:291-5.
2. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and cardiovascular disease. Annu Rev Med 1998;49:31-62.
3. Blacher J, Demuth K, Guerin AP et al. Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. J Nephrol 1999;12:248-55.
4. Sundstrom J, Sullivan L, Selhub J et al. Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study. Eur Heart J 2004;25:523-30.
5. Joseph J, Joseph L, Shekhawat NS et al. Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats. Am J Physiol Heart Circ Physiol 2003;285:H679-86.
6. Walker E, Black J, Parris C et al. Effect of experimental hyperhomocysteinemia on cardiac structure and function in the rat. Ann Clin Lab Sci 2004;34(2):175-80.
7. Dahlof B. Left ventricular hypertrophy and angiotensin II antagonists. Am J Hypertens 2001;14:174-82.
8. 2 receptors: regulation, signalling and function. Blood Press 2003; 12:70-88.
9. Mujumdar VS, Hayden MR, Tyagi SC. Homocyst(e)ine induces calcium second messenger in vascular smooth muscle cells. J Cell Physiol 2000; 183:28-36.
10. Bonaventura D, Tirapelli CR, Haddad R, Hoehr NF, Eberlin MN, de Oliveira AM. Chronic methionine load-induced hyperhomocysteinemia enhances rat carotid responsiveness for angiotensin II. Pharmacology 2004;70:91-9.
11. Neves MF, Endemann D, Amiri F et al. Small artery mechanics in hyperhomocysteinemic mice: effects of angiotensin II. J Hypertens 2004;22:959-66.
12. Kassab S, Abu-Hijleh M, Al-Shaikh H, Das NS. Hyperhomocysteinemia in pregnant rats: Effects on arterial pressure, kidneys and fetal growth. Eur J Obstet Gynecol Reprod Biol 2005; 122:177-81.
13. Li N, Chen YF, Zou AP. Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension 2002;39:443-8.
14. Junquiera LC, Bignolas G, Brentani RR. A simple and sensitive method for the quantitative estimation of collagen. Anal Biochem 1979;94:96-9.
15. Lopez-De Leon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 1985;33:737-43.
16. Rolland PH, Friggi A, Barlatier A et al. Hyperhomocysteinemia-induced vascular damage in the minipig: Captopril-hydrochlorothiazide combination prevents elastic alterations. Circulation 1995;91:1161-74.
17. Robin S, Maupoil V, Laurant P, Jacqueson A, Berchelot A. Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats. Br J Nutr 2004;91:857-65.
18. Lim U, Cassano PA. Homocysteine and blood pressure in the Third Nathional Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2002;156:1105-13.
19. Van Guldener C, Stehouwer CD. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction. Semin Thromb Hemost 2000;26:281-9.
20. Tyagi SC, Smiley LM, Mujumdar VS. Homocyst(e)ine impairs endocardial endothelial function. Can J Physiol Pharmacol 1999;77:950-7.
21. Miller A, Mujumdar V, Palmer L, Bower JD, Tyagi SC. Reversal of endocardial endothelial dysfunction by folic acid in homocysteinemic hypertensive rats. Am J Hypertens 2002;15:157-63.
22. Petrov VV, Fagard RH, Lijnen PJ. Transforming growth factor-beta (1) induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts. JRAAS 2000;1:342-52.
23. Suzuki YJ, Shi SS, Blumberg JB. Modulation of angiotensin II signaling for GATA4 activation by homocysteine. Antioxid Redox Signal 1999;11:233-38.
24. Bokhari SW, Bokhari ZW, Zell JA, Lee DW, Faxon DP. Plasma homocysteine levels and the left ventricular systolic function in coronary artery disease patients. Coronary Artery Disease 2005;16;153-61.